BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32912834)

  • 1. Minimal main pancreatic duct dilatation in small branch duct intraductal papillary mucinous neoplasms associated with high-grade dysplasia or invasive carcinoma.
    Amini N; Rezaee N; Habib JR; Blair A; Beckman RM; Manos L; Cameron JL; Hruban RH; Weiss MJ; Fishman EK; Zaheer A; Lafaro KJ; Burkhart RA; O'Broin Lennon AM; Burns WR; He J; Wolfgang CL
    HPB (Oxford); 2021 Mar; 23(3):468-474. PubMed ID: 32912834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can contrast-enhanced harmonic endoscopic ultrasonography accurately diagnose main pancreatic duct involvement in intraductal papillary mucinous neoplasms?
    Ohno E; Kawashima H; Ishikawa T; Iida T; Suzuki H; Uetsuki K; Yashika J; Yamada K; Yoshikawa M; Gibo N; Aoki T; Kataoka K; Mori H; Hirooka Y; Fujishiro M
    Pancreatology; 2020 Jul; 20(5):887-894. PubMed ID: 32651080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Main duct and mixed type intraductal papillary mucinous neoplasms without enhancing mural nodules: Duct diameter of less than 10 mm and segmental dilatation of main pancreatic duct are findings support surveillance rather than immediate surgery.
    Kim TH; Song TJ; Lee SO; Park CH; Moon JH; Pih GY; Oh DW; Woo SM; Yang YJ; Kim MH
    Pancreatology; 2019 Dec; 19(8):1054-1060. PubMed ID: 31611130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Branch-duct intraductal papillary mucinous neoplasm (IPMN): Are cyst volumetry and other novel imaging features able to improve malignancy prediction compared to well-established resection criteria?
    Pozzi Mucelli RM; Moro CF; Del Chiaro M; Valente R; Blomqvist L; Papanikolaou N; Löhr JM; Kartalis N
    Eur Radiol; 2022 Aug; 32(8):5144-5155. PubMed ID: 35275259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncinate duct dilation in intraductal papillary mucinous neoplasms of the pancreas: a radiographic finding with potentially increased malignant potential.
    Ammori JB; Do RK; Brennan MF; D'Angelica MI; Dematteo RP; Fong Y; Jarnagin WR; Allen PJ
    J Gastrointest Surg; 2014 May; 18(5):911-6. PubMed ID: 24448998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
    Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
    Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: implications of minimal involvement of the main pancreatic duct.
    Sahora K; Fernández-del Castillo C; Dong F; Marchegiani G; Thayer SP; Ferrone CR; Sahani DV; Brugge WR; Warshaw AL; Lillemoe KD; Mino-Kenudson M
    Surgery; 2014 Sep; 156(3):611-21. PubMed ID: 25081232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
    Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging Features for Predicting High-Grade Dysplasia or Malignancy in Branch Duct Type Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Systematic Review and Meta-Analysis.
    Zhao W; Liu S; Cong L; Zhao Y
    Ann Surg Oncol; 2022 Feb; 29(2):1297-1312. PubMed ID: 34554343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriate indications of initial endoscopic ultrasound evaluation for detecting mural nodules in branch duct intraductal papillary mucinous neoplasms of the pancreas.
    Kim YI; Woo SM; Lee WJ; Han SS; Park SJ; Kim TH; Koh YH; Hong EK
    Scand J Gastroenterol; 2013 May; 48(5):610-6. PubMed ID: 23597152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
    Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
    Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm.
    Tang RS; Weinberg B; Dawson DW; Reber H; Hines OJ; Tomlinson JS; Chaudhari V; Raman S; Farrell JJ
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):815-9; quiz 719. PubMed ID: 18602036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A resected case of two branch duct-type intraductal papillary mucinous neoplasms showing different clinical courses after a two-year follow-up.
    Shibata H; Ohike N; Norose T; Isobe T; Suzuki R; Imai H; Shiokawa A; Takimoto M; Tabuchi A; Takano Y; Yamamura E; Nagahama M; Takeyama N; Yokomizo K; Mizukami H; Tanaka JI; Aoki T; Murakami M
    Clin J Gastroenterol; 2017 Jun; 10(3):274-278. PubMed ID: 28258561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk.
    Fritz S; Klauss M; Bergmann F; Strobel O; Schneider L; Werner J; Hackert T; Büchler MW
    Ann Surg; 2014 Nov; 260(5):848-55; discussion 855-6. PubMed ID: 25379856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Threshold of main pancreatic duct for malignancy in intraductal papillary mucinous neoplasm at head-neck and body-tail.
    Zhou H; Li X; Wang Y; Wang Z; Zhu J; Wang Z; Chen X
    BMC Gastroenterol; 2022 Nov; 22(1):473. PubMed ID: 36402960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of malignancy with endoscopic ultrasonography in patients with branch duct-type intraductal papillary mucinous neoplasm.
    Lee KH; Lee SJ; Lee JK; Ryu JK; Kim EY; Kim TH; Moon JH; Lee WJ; Cho YK; Kim JJ
    Pancreas; 2014 Nov; 43(8):1306-11. PubMed ID: 25036913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncinate Duct Dilatation Predicts Additional Risk for High-Grade Dysplasia or Invasive Carcinoma Among Fukuoka-Positive Intraductal Papillary Mucinous Neoplasms.
    Yang AZ; Kongboonvijit S; Fernandez-Del Castillo CF; Fong ZV; Zelga PJ; Ferrone CR; Lillemoe KD; Kambadakone A; Qadan M
    Ann Surg; 2023 Jun; 277(6):988-994. PubMed ID: 36804283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancer.
    Nguyen AH; Toste PA; Farrell JJ; Clerkin BM; Williams J; Muthusamy VR; Watson RR; Tomlinson JS; Hines OJ; Reber HA; Donahue TR
    J Gastrointest Surg; 2015 Feb; 19(2):258-65. PubMed ID: 25373706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography.
    Harima H; Kaino S; Shinoda S; Kawano M; Suenaga S; Sakaida I
    World J Gastroenterol; 2015 May; 21(20):6252-60. PubMed ID: 26034360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.